Jialei Sun

1.7k total citations · 1 hit paper
53 papers, 1.1k citations indexed

About

Jialei Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Food Science. According to data from OpenAlex, Jialei Sun has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Food Science. Recurrent topics in Jialei Sun's work include Ferroptosis and cancer prognosis (10 papers), Probiotics and Fermented Foods (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jialei Sun is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Probiotics and Fermented Foods (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jialei Sun collaborates with scholars based in China, United States and Taiwan. Jialei Sun's co-authors include Chenhao Zhou, Ning Ren, Wanyong Chen, Xue Han, Qiang Zhou, Lanwei Zhang, Biwei Yang, Jinglin Xia, Ji‐Min Zhu and Pimin Gong and has published in prestigious journals such as Cell, Nature Communications and Gastroenterology.

In The Last Decade

Jialei Sun

52 papers receiving 1.1k citations

Hit Papers

Gut-liver axis calibrates intestinal stem cell fitness 2024 2026 2025 2024 10 20 30 40

Peers

Jialei Sun
Guoqing Qian United States
Bin Jiang China
Yan Du China
Lei Bao China
Jialei Sun
Citations per year, relative to Jialei Sun Jialei Sun (= 1×) peers Jianping Wang

Countries citing papers authored by Jialei Sun

Since Specialization
Citations

This map shows the geographic impact of Jialei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialei Sun more than expected).

Fields of papers citing papers by Jialei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialei Sun. The network helps show where Jialei Sun may publish in the future.

Co-authorship network of co-authors of Jialei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jialei Sun. A scholar is included among the top collaborators of Jialei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialei Sun. Jialei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jialei, et al.. (2025). Calcium and magnesium improve Lactobacillus bulgaricus survival via membrane and metabolic protection. LWT. 234. 118584–118584. 1 indexed citations
2.
Wu, Suiyi, Yuanyuan Zhu, Jialei Sun, et al.. (2025). Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation. Nature Communications. 16(1). 10039–10039. 1 indexed citations
3.
Sun, Jialei, et al.. (2025). PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. Advanced Science. 12(30). e04372–e04372.
4.
Zhang, Guangcong, Kang Song, Jun Du, et al.. (2024). Bismuth-based mesoporous nanoball carrying sorafenib for synergistic photothermal and molecularly-targeted therapy in an orthotopic hepatocellular carcinoma xenograft mouse model. Colloids and Surfaces B Biointerfaces. 245. 114279–114279. 2 indexed citations
6.
Wang, Fu, Weiqi Xu, Wanqin Zhang, et al.. (2023). Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway. Hepatology International. 18(2). 636–650. 7 indexed citations
7.
Zhang, Guangcong, Xiang‐Nan Yu, Hongying Guo, et al.. (2023). PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism. Cancer Research. 83(4). 521–537. 20 indexed citations
8.
Liu, Zhiyong, Guobo Chen, Xiang Wang, et al.. (2023). Synergistic Photochemo Effects Based on Light‐Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy. Advanced Healthcare Materials. 12(27). e2301133–e2301133. 10 indexed citations
9.
Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2023). Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 164(7). 1261–1278. 76 indexed citations
11.
Zhou, Chenhao, Jialei Weng, Shaoqing Liu, et al.. (2023). Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA. Hepatology International. 17(6). 1461–1476. 3 indexed citations
12.
Wang, Fu, Jialei Sun, Guangcong Zhang, et al.. (2022). A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Journal of Translational Medicine. 20(1). 579–579. 2 indexed citations
13.
Wang, Xiang, Jialei Sun, Guangcong Zhang, et al.. (2022). Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(33). 37356–37368. 20 indexed citations
14.
Sun, Jialei, et al.. (2022). The effect of extracellular protease secreted by Pseudomonas fluorescens W3 on the quality of UHT milk. Journal of Food Processing and Preservation. 46(7). 2 indexed citations
15.
Du, Jun, Zhiyong Liu, Guangcong Zhang, et al.. (2022). Sorafenib-Loaded Cu2−xSe Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma. Nanomaterials. 12(18). 3191–3191. 12 indexed citations
16.
Sun, Jialei, Ning‐Ping Zhang, Guangcong Zhang, et al.. (2021). Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. Journal of Translational Medicine. 19(1). 347–347. 36 indexed citations
17.
Cui, Baolu, et al.. (2021). Effect of rare earth oxides on the formation of gaseous products from low rank coal pyrolysis. Energy Sources Part A Recovery Utilization and Environmental Effects. 47(1). 11523–11536. 1 indexed citations
18.
Shi, Xuan, Taotao Liu, Xiang‐Nan Yu, et al.. (2020). microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene. 39(35). 5768–5781. 41 indexed citations
19.
Yu, Xiang‐Nan, Guangcong Zhang, Jialei Sun, et al.. (2020). Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 27(5). 1546–1557. 11 indexed citations
20.
Zeng, Zhao‐Chong, Jia Fan, Zhao–You Tang, et al.. (2013). Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases. Clinical & Translational Oncology. 15(9). 732–740. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026